Back to Search
Start Over
Zinc(II)—The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19?
- Source :
- Pharmaceuticals, Vol 13, Iss 9, p 228 (2020)
- Publication Year :
- 2020
- Publisher :
- MDPI AG, 2020.
-
Abstract
- Zn(II) is an inhibitor of SARS-CoV-2′s RNA-dependent RNA polymerase, and chloroquine and hydroxychloroquine are Zn(II) ionophores–this statement gives a curious mind a lot to think about. We show results of the first clinical trials on chloroquine (CQ) and hydroxychloroquine (HCQ) in the treatment of COVID-19, as well as earlier reports on the anticoronaviral properties of these two compounds and of Zn(II) itself. Other FDA-approved Zn(II) ionophores are given a decent amount of attention and are thought of as possible COVID-19 therapeutics.
Details
- Language :
- English
- ISSN :
- 14248247
- Volume :
- 13
- Issue :
- 9
- Database :
- Directory of Open Access Journals
- Journal :
- Pharmaceuticals
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.9bf128aa1d5842bfb46cd1befcd105db
- Document Type :
- article
- Full Text :
- https://doi.org/10.3390/ph13090228